R-Pharm Group
is one of the leaders of the Russian pharmaceutical market
- The mission of R-Pharm is to increase the accessibility of the most modern medicines for patients in Russia and all over the world.
R-Pharm specializes in research and development, manufacturing of high-tech medicines, as well as the distribution of laboratory supplies and medical equipment. Various Russian leading medical institutions and organizations are among the clients of the group.
The staff consists of more than 3,000 highly qualified professionals. There are more than 70 branches and representative offices. R-Pharm’s headquarters are located in Moscow.
History
2001-2004
Foundation of R-Pharm company focused on supply of pharmaceutical products for hospital and secondary care
Establishment of regional branch network
2005-2008Receiving of Trace International Certificate
Partnering with international leaders in the pharmaceutical manufacturing
2009-2012Establishment of the company R-Pharm Overseas, Inc. in San-Diego, USA
Acquisition of “Novosibhimfarm” factory in Novosibirsk
Acquisition of “Ortat” factory in the Kostroma Region
Construction of a plant manufacturing finished dosage form in Yaroslavl
2012-2015Development of cooperative projects in Belarus, Kazakhstan, Azerbaijan
Commencement of operating activities in the USA
Enhanced cooperation with Japanese companies and universities
Establishment of a subsidiary enterprise in Turkey
Enhanced international cooperation: technology transfer to the enterprises of R-pharm (in accordance with the programme «Pharma-2020»
2016-2017Acquisition of 10% of the shares of Russian pharmaceutical company R-Pharm by Japanese company Mitsui&Company, Ltd.
Expansion of production capacities. Opening of biopharmaceutical manufacturing using GE Healthcare technologies
Commencement of joint Russian-Azerbaijanian manufacture construction LLC «Hayam Pharm» in Baku, Azerbaijan
2005-2008
2009-2012
2012-2015
2016-2017
Manufacturing
R-Pharm Group owns several state-of-the-art manufacturing sites in Russia and abroad: high-tech packaging site in Kostroma region, a plant for production of finished dosage forms and biotechnological APS in Yaroslavl, pilot manufacturing site in Moscow, a plant for production of solid dosage forms in Illertissen (Germany). A modern research and APS manufacturing site in Rostov and Russian-Azerbaijani pharmaceutical plant in Baku are under construction. In 2018 R-Pharm and Rosatom agreed to create a joint manufacturing plant in Moscow.
Research and Development
R-Pharm has its own research and development facilities, which allows it to conduct various activities in partnership with the leading Russian and foreign academic institutes.
R-pharm signed numerous agreements on product manufacturing localization, technology transfer and licensing with the biggest pharmaceutical companies from all over the world.
The portfolio of the group includes medicines for various therapeutic areas : oncological, hematologic, cardiological, immunological, antibacterial, antiviral, including HIV therapy, pharmaceuticals used during and after organ transplantation, treatment of multiple sclerosis, hemophilia, as well as muscle relaxants, contrast agents and anesthetics.
The company actively carries out charitable work, supports educational, social, cultural, sport and health projects, implements training programs and conducts internships for talented Russian students and young scientists.